Zoledronic Acid Preserves Bone Structure and Increases Survival but Does Not Limit Tumour Incidence in a Prostate Cancer Bone Metastasis Model

• Tzong-Tyng Hung,

  Affiliations Prince of Wales Clinical School, Prince of Wales Hospital, Randwick, New South Wales, Australia, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia

  ⨯
• Jeffrey Chan,

  Affiliations Centre for Vascular Research, University of New South Wales, Sydney, New South Wales, Australia, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia

  ⨯
• Pamela J. Russell,

  Affiliation Australian Prostate Cancer Research Centre- Queensland, Princess Alexandra Hospital, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia

  ⨯
• Carl A. Power

  * E-mail: c.power@unsw.edu.au

  Affiliations Prince of Wales Clinical School, Prince of Wales Hospital, Randwick, New South Wales, Australia, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia

  ⨯